IGC Pharma Profit Margin

IGC Pharma (IGC) currently reports a profit margin of -702.14% as of June 2026. That compares with -477.92% in the prior-year period — down 46.9% year over year. That is below the Healthcare sector average of 14.41%. Use the charts on this page to explore IGC Pharma's profit margin history and peer comparisons.

IGC Pharma's profit margin decreased from -477.92% to -702.14% — a 46.9% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

IGC Pharma's profit margin of -702.14% is lower than the Healthcare sector average of 14.41%. That is roughly 4971.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but IGC Pharma's current -702.14% should be judged against Healthcare norms (sector average: 14.41%) and against IGC's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -702.14%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 14.41%. From there, open related valuation or income-statement pages for IGC Pharma, and consider following IGC for alerts when major investors trade the stock.